title: [In Process Citation].
abstract: Peritoneal carcinosis is considered to be a lethal disease with a very poor prognosis, however cytoreducticve surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) could represent a significant step forward in the therapy of peritoneal cranosis. In contrast to traditional surgical procedures and intravenous chemotherapy, which are moderately effective, CRS and HIPEC are new, personalised interventions, which can extend the lifespan of the patients in the majority of the cases. Moreover, there is a possibility to carry out definitive, curative therapy in a well-selected group of cases. The aim of this article is to review the relevant literature on these procedures, which are novelties in Hungary, and to include our own experience, too.
authors.affiliation: Általános Sebészet, Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház 4400 Nyíregyháza, Szent István u. 68.
authors.forename: Lajos Barna
authors.initials: LB
authors.lastname: Tóth
authors.affiliation: Általános Orvostudományi Kar, Debreceni Egyetem Debrecen.
authors.forename: Róza
authors.initials: R
authors.lastname: Bartók
authors.affiliation: Általános Sebészet, Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház 4400 Nyíregyháza, Szent István u. 68.
authors.forename: Sándor
authors.initials: S
authors.lastname: Bogdán Rajcs
authors.affiliation: AITO, Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház Nyíregyháza.
authors.forename: Gábor
authors.initials: G
authors.lastname: Szigligeti
keywords: carcinosis peritonei; cytoreductiv műtét (CRS); cytoreductive surgery (CRS); hashártyaáttétek; hyperthermic intraperitoneal chemotherapy (HIPEC); hyperthermiás intraperitonealis chemotherapia (HIPEC); peritoneal metastases; peritonealis carcinosis; pseudomyxoma peritonei